دورية أكاديمية

Long-Term Follow-Up of Health-Related Quality of Life and Short-Term Intervention with CFTR Modulator Therapy in Adults with Cystic Fibrosis: Evaluation of Changes over Several Years with or without 33 Weeks of CFTR Modulator Therapy

التفاصيل البيبلوغرافية
العنوان: Long-Term Follow-Up of Health-Related Quality of Life and Short-Term Intervention with CFTR Modulator Therapy in Adults with Cystic Fibrosis: Evaluation of Changes over Several Years with or without 33 Weeks of CFTR Modulator Therapy
المؤلفون: Wolfgang Gruber, Matthias Welsner, Christopher Blosch, Stefanie Dillenhoefer, Margarete Olivier, Folke Brinkmann, Cordula Koerner-Rettberg, Sivagurunathan Sutharsan, Uwe Mellies, Christian Taube, Florian Stehling
المصدر: Healthcare, Vol 11, Iss 21, p 2873 (2023)
بيانات النشر: MDPI AG, 2023.
سنة النشر: 2023
المجموعة: LCC:Medicine
مصطلحات موضوعية: cystic fibrosis, adults, health-related quality of life, Elexacaftor/Tezacaftor/Ivacaftor, longitudinal changes, Medicine
الوصف: Background: Longitudinal data on changes in health-related quality of life (HRQoL) in adult people with cystic fibrosis (pwCF) and the longitudinal effects of Elexacaftor/Tezacaftor/Ivacaftor therapy (ETI) on HRQoL or HRQoL domains are currently scarce. This study aimed to investigate the effects of ETI on HRQoL and compare them with those of pwCF who did not receive highly effective CFTR modulators over a longer period. Methods: Baseline assessment and follow-up data for 5.6 years in pwCF with (n = 21) and 6.5 years in pwCF without (n = 6) ETI (≥18 years) were evaluated. The assessment of HRQoL and clinical parameters was identical at both time points. HRQoL was assessed using the CFQ-R, and clinical outcomes included BMI, ppFEV1, and FEV1 z-score. Results: ETI was found to improve all HRQoL domains at more than four points over time, and their increases were significant except for vitality, digestion, treatment burden, and social functioning (p < 0.05). Without ETI, psychosocial domains remained almost constant, whereas most physical domains decreased over time. Conclusions: The results of the present study show that ETI therapy has a positive effect on HRQoL and clinical outcomes over time but not in pwCF without ETI treatment. Furthermore, our results suggest that disease progression over time affects the physical domains of HRQoL more than the psychosocial domains. Due to the small sample size and the heterogeneity of the study population (CFTR mutation genotype), the results should be interpreted with some caution.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2227-9032
Relation: https://www.mdpi.com/2227-9032/11/21/2873; https://doaj.org/toc/2227-9032
DOI: 10.3390/healthcare11212873
URL الوصول: https://doaj.org/article/e581a27894dd49b29181e7d94c5c576e
رقم الأكسشن: edsdoj.581a27894dd49b29181e7d94c5c576e
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:22279032
DOI:10.3390/healthcare11212873